vs
Side-by-side financial comparison of Cytek Biosciences, Inc. (CTKB) and Ponce Financial Group, Inc. (PDLB). Click either name above to swap in a different company.
Cytek Biosciences, Inc. is the larger business by last-quarter revenue ($62.1M vs $31.4M, roughly 2.0× Ponce Financial Group, Inc.). Ponce Financial Group, Inc. runs the higher net margin — 36.3% vs -70.9%, a 107.2% gap on every dollar of revenue. On growth, Ponce Financial Group, Inc. posted the faster year-over-year revenue change (37.6% vs 8.1%). Ponce Financial Group, Inc. produced more free cash flow last quarter ($54.6M vs $-1.8M). Over the past eight quarters, Ponce Financial Group, Inc.'s revenue compounded faster (23.7% CAGR vs 17.7%).
Cytek Biosciences, Inc. develops, manufactures and sells high-performance flow cytometry systems, associated reagents and analysis software. Its solutions serve life science research, clinical diagnostics and biopharmaceutical sectors, with a global customer base across North America, Europe and the Asia-Pacific region.
Ponce Financial Group, Inc. is a U.S.-based financial holding company operating Ponce Bank as its core subsidiary. It serves multicultural, immigrant and low-to-moderate income communities in the New York metro area, offering retail and commercial banking products including deposits, mortgages, small business financing and personal credit.
CTKB vs PDLB — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $62.1M | $31.4M |
| Net Profit | $-44.1M | $10.1M |
| Gross Margin | 52.9% | — |
| Operating Margin | -9.0% | 43.6% |
| Net Margin | -70.9% | 36.3% |
| Revenue YoY | 8.1% | 37.6% |
| Net Profit YoY | -557.1% | 245.6% |
| EPS (diluted) | — | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $62.1M | $31.4M | ||
| Q3 25 | $52.3M | $26.7M | ||
| Q2 25 | $45.6M | $26.5M | ||
| Q1 25 | $41.5M | $24.6M | ||
| Q4 24 | $57.5M | $22.8M | ||
| Q3 24 | $51.5M | $20.2M | ||
| Q2 24 | $46.6M | $20.2M | ||
| Q1 24 | $44.9M | $20.5M |
| Q4 25 | $-44.1M | $10.1M | ||
| Q3 25 | $-5.5M | $6.5M | ||
| Q2 25 | $-5.6M | $6.1M | ||
| Q1 25 | $-11.4M | $6.0M | ||
| Q4 24 | $9.6M | $2.9M | ||
| Q3 24 | $941.0K | $2.4M | ||
| Q2 24 | $-10.4M | $3.2M | ||
| Q1 24 | $-6.2M | $2.4M |
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
| Q4 25 | -9.0% | 43.6% | ||
| Q3 25 | -17.6% | 32.8% | ||
| Q2 25 | -23.3% | 30.2% | ||
| Q1 25 | -36.1% | 32.5% | ||
| Q4 24 | 5.2% | 19.6% | ||
| Q3 24 | -8.2% | 15.2% | ||
| Q2 24 | -18.3% | 21.8% | ||
| Q1 24 | -23.9% | 18.3% |
| Q4 25 | -70.9% | 36.3% | ||
| Q3 25 | -10.5% | 24.3% | ||
| Q2 25 | -12.2% | 23.0% | ||
| Q1 25 | -27.5% | 24.2% | ||
| Q4 24 | 16.8% | 14.1% | ||
| Q3 24 | 1.8% | 12.1% | ||
| Q2 24 | -22.4% | 15.8% | ||
| Q1 24 | -13.8% | 11.8% |
| Q4 25 | — | $0.43 | ||
| Q3 25 | — | $0.27 | ||
| Q2 25 | — | $0.25 | ||
| Q1 25 | — | $0.25 | ||
| Q4 24 | — | $0.11 | ||
| Q3 24 | — | $0.10 | ||
| Q2 24 | — | $0.14 | ||
| Q1 24 | — | $0.11 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $90.9M | $126.2M |
| Total DebtLower is stronger | — | $596.1M |
| Stockholders' EquityBook value | $341.7M | $541.5M |
| Total Assets | $461.5M | $3.2B |
| Debt / EquityLower = less leverage | — | 1.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $90.9M | $126.2M | ||
| Q3 25 | $93.3M | $146.6M | ||
| Q2 25 | $75.5M | $126.6M | ||
| Q1 25 | $95.3M | $129.9M | ||
| Q4 24 | $98.7M | $139.8M | ||
| Q3 24 | $162.3M | $155.8M | ||
| Q2 24 | $177.9M | $103.2M | ||
| Q1 24 | $168.8M | $134.7M |
| Q4 25 | — | $596.1M | ||
| Q3 25 | — | $521.1M | ||
| Q2 25 | — | $536.1M | ||
| Q1 25 | — | $521.1M | ||
| Q4 24 | — | $596.1M | ||
| Q3 24 | — | $580.4M | ||
| Q2 24 | — | $680.4M | ||
| Q1 24 | — | $680.4M |
| Q4 25 | $341.7M | $541.5M | ||
| Q3 25 | $378.6M | $529.8M | ||
| Q2 25 | $377.6M | $521.1M | ||
| Q1 25 | $379.6M | $513.9M | ||
| Q4 24 | $395.7M | $505.5M | ||
| Q3 24 | $385.5M | $504.6M | ||
| Q2 24 | $389.1M | $497.7M | ||
| Q1 24 | $392.6M | $493.7M |
| Q4 25 | $461.5M | $3.2B | ||
| Q3 25 | $494.9M | $3.2B | ||
| Q2 25 | $493.3M | $3.2B | ||
| Q1 25 | $482.6M | $3.1B | ||
| Q4 24 | $499.5M | $3.0B | ||
| Q3 24 | $491.2M | $3.0B | ||
| Q2 24 | $483.7M | $2.8B | ||
| Q1 24 | $492.1M | $2.8B |
| Q4 25 | — | 1.10× | ||
| Q3 25 | — | 0.98× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.01× | ||
| Q4 24 | — | 1.18× | ||
| Q3 24 | — | 1.15× | ||
| Q2 24 | — | 1.37× | ||
| Q1 24 | — | 1.38× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-771.0K | $55.6M |
| Free Cash FlowOCF − Capex | $-1.8M | $54.6M |
| FCF MarginFCF / Revenue | -2.9% | 173.9% |
| Capex IntensityCapex / Revenue | 1.6% | 3.1% |
| Cash ConversionOCF / Net Profit | — | 5.48× |
| TTM Free Cash FlowTrailing 4 quarters | $-8.8M | $74.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-771.0K | $55.6M | ||
| Q3 25 | $-3.9M | $1.4M | ||
| Q2 25 | $108.0K | $6.2M | ||
| Q1 25 | $-125.0K | $13.1M | ||
| Q4 24 | $2.0M | $7.2M | ||
| Q3 24 | $13.2M | $-14.6M | ||
| Q2 24 | $6.2M | $-2.6M | ||
| Q1 24 | $4.0M | $1.5M |
| Q4 25 | $-1.8M | $54.6M | ||
| Q3 25 | $-4.6M | $786.0K | ||
| Q2 25 | $-1.5M | $5.9M | ||
| Q1 25 | $-974.0K | $12.9M | ||
| Q4 24 | $1.1M | $4.5M | ||
| Q3 24 | $12.2M | $-15.0M | ||
| Q2 24 | $5.2M | $-2.6M | ||
| Q1 24 | $3.4M | $-315.0K |
| Q4 25 | -2.9% | 173.9% | ||
| Q3 25 | -8.7% | 2.9% | ||
| Q2 25 | -3.2% | 22.4% | ||
| Q1 25 | -2.3% | 52.6% | ||
| Q4 24 | 1.9% | 19.7% | ||
| Q3 24 | 23.7% | -74.1% | ||
| Q2 24 | 11.0% | -13.0% | ||
| Q1 24 | 7.6% | -1.5% |
| Q4 25 | 1.6% | 3.1% | ||
| Q3 25 | 1.3% | 2.3% | ||
| Q2 25 | 3.5% | 1.0% | ||
| Q1 25 | 2.0% | 0.6% | ||
| Q4 24 | 1.6% | 11.9% | ||
| Q3 24 | 2.0% | 2.0% | ||
| Q2 24 | 2.3% | 0.3% | ||
| Q1 24 | 1.3% | 8.7% |
| Q4 25 | — | 5.48× | ||
| Q3 25 | — | 0.21× | ||
| Q2 25 | — | 1.01× | ||
| Q1 25 | — | 2.20× | ||
| Q4 24 | 0.21× | 2.46× | ||
| Q3 24 | 14.05× | -5.99× | ||
| Q2 24 | — | -0.80× | ||
| Q1 24 | — | 0.61× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
PDLB
Segment breakdown not available.
